| Zeit | Titel | Quelle |
| 17.07.26 | Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA | PR Newswire |
| 17.07.26 | Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA | PR Newswire |
| 01.06.26 | Camurus announces expansion of Lilly collaboration | PR Newswire |
| 01.06.26 | Camurus announces expansion of Lilly collaboration | PR Newswire |
| 09.01.26 | Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly | PR Newswire |
| 09.01.26 | Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly | PR Newswire |
| Kaufen | Halten | Verkaufen | |
|---|---|---|---|
| Analysten | 0 | 0 | 0 |
| Markt-Lotsen | 0 | 0 | 0 |